| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7503813 | Drug and Alcohol Dependence | 2016 | 5 Pages |
Abstract
Repeated 5-HT2A receptor inverse agonist/antagonist treatment did not attenuate methamphetamine reinforcement under a concurrent schedule of intravenous methamphetamine and food presentation in nonhuman primates. Overall, these results do not support the therapeutic potential of 5-HT2A inverse agonists/antagonists as candidate medications for methamphetamine addiction.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Matthew L. Banks,